Turacoz Group

𝟮.𝟮 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗥𝗲𝗮𝘀𝗼𝗻𝘀 𝘁𝗼 #𝗟𝗼𝘃𝗲𝗬𝗼𝘂𝗿𝗘𝘆𝗲𝘀 𝘁𝗵𝗶𝘀 𝗪𝗼𝗿𝗹𝗱 𝗦𝗶𝗴𝗵𝘁 𝗗𝗮𝘆

Vision impairment affects people of all ages and poses an enormous global financial burden. The annual cost to productivity is estimated at US$ 411 billion.

But the good news? Half of all vision impairments are preventable or treatable. With early detection, timely interventions, and regular eye care, we can significantly reduce the impact of vision loss and enhance the quality of life for individuals at all stages of life.

At Turacoz, we’re dedicated to supporting eye health by creating evidence-based content and resources that drive awareness and inform key healthcare communications. By empowering patients and equipping healthcare professionals, we help bridge the gap to better access and outcomes.

Prioritizing eye health is an ongoing commitment that benefits everyone, irrespective of age.

If you're looking to enhance your eye health communications, let's connect and explore how we can support your initiatives.

𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗮𝘁

From October 7–9, Barcelona will host Europe’s largest national-led biotech gathering, bringing together innovators, researchers, and industry leaders to advance healthcare solutions.

Turacoz is proud to be part of this dialogue. Representing our team at Biospain 2025 will be Dr Namrata. Singh (Founder & CEO) and Farzaneh Norouzi (Business Development Consultant).

Looking forward to connecting, exchanging ideas, and exploring new opportunities to shape the future of healthcare together.

Day one of the LSX World Congress 2025 event in Boston gave us a great experience for networking. Our leadership team, Dr Namrata., CEO of Turacoz and Sasi Bhushaan Kuchibothla , Director of Business Excellence Unit (Europe & USA) explored promising business conversations with clinical stage biotech and pharma companies and attended several insightful sessions focused on obesity therapeutic area, adapting AI tool in medicinal product development operations and on early stage and clinical stage investing strategies.

It was great to see senior pharma/biotech leader, investors and early stage innovators attending LSX world congress 2025 event and our team found few opportunities to collaborate with pharma leaders in the US and discussed especially about the importance of scientific and medical communications in accelerating product time to market with emphasis on HEOR, RWE, medical education, KOL engagement and regulatory writing.

If you are at LSX world congress on day 2, don’t miss the opportunity to meet with Turacoz Leadership to discuss on medical affairs strategy for your products in early stage and late stage development while navigating the dynamic regulatory landscape. Reach us on Partnering One platform to setup meetings with Turacoz or email us at [email protected]

, , , ,